UiPath Q4 Results Show ARR Growth and Profit, But Critical Metrics Remain Unverified

What happened

UiPath reported strong Q4 fiscal 2026 results with 14% revenue growth, $1.853 billion in annual recurring revenue, and its first full-year GAAP profit, attributed to accelerating AI-driven automation adoption. This ARR figure exceeds the $1.782 billion from Q3 FY26 highlighted in the DeepValue report, where growth was at 11% year-over-year amid skepticism about monetization. The full-year GAAP profit marks a milestone, but the report cautions that profitability quality must be assessed beyond potential one-off tax benefits. Critical investor focus remains on dollar-based net retention rate (DBNRR), which was at 107% in Q3 FY26, and net new ARR, as improvement is necessary to validate that agentic automation is driving sustainable expansion. Therefore, while the quarterly performance appears positive, the fundamental proof points required for a re-acceleration narrative are still pending detailed disclosure.

Implication

UiPath's higher ARR and full-year profit provide initial evidence that its agentic automation initiatives may be gaining commercial traction, aligning with the base scenario in the DeepValue report. However, without updated DBNRR data, it's unclear if customer expansion rates have improved from the 107% level, a key threshold for validating the investment thesis. The profitability achievement could bolster market sentiment, but as the report notes, operating income and cash flow are more reliable indicators than net income due to potential tax-related volatility. This development may shift the narrative from pure 'show-me' skepticism to cautious optimism, but sustained stock appreciation will depend on subsequent quarterly reports confirming that net new ARR sustains above $50 million and DBNRR rises. Investors should view this as a positive step but maintain discipline by awaiting the next earnings cycle for comprehensive metrics before increasing exposure.

Thesis delta

The thesis shifts slightly towards optimism as ARR growth surpasses prior expectations and profitability is achieved, potentially supporting the bull scenario if expansion metrics improve. However, the core requirement for DBNRR to rise above 107% and net new ARR to sustain higher levels remains unverified, keeping the thesis in a 'confirmatory' phase rather than a decisive re-rate. Until these key indicators are reported, the investment call stays at 'potential buy' with heightened focus on execution proof in the upcoming quarters.